Infinium Global Research Muscle Relaxants Drugs Market | Page 3

Muscle Relaxants Drugs Market: Trends and Forecasts up to 2024
usage in cosmetic industry can create a demand for muscle relaxant market in near
future.
Geographically, North America held the largest market share in 2017. The factors
such as increase awareness about muscle relaxant drugs, adoption of online
shopping for drugs are the factors driving growth in this region. Asia Pacific is
expected to be the fastest growing CAGR among other regions owing to huge
population base, rising stress/ tension level and improving healthcare
infrastructures in this region.
Segment Covered
The report on global muscle relaxants drugs market covers segments such as, drugs
type and distribution channel. On the basis of drugs type the global muscle
relaxants drugs market is categorized into facial muscle relaxant market, skeletal
muscle relaxant market and neuromuscular relaxant market. On the basis of
distribution channel the global muscle relaxants drugs market is categorized into
drug stores, hospitals, clinics and online stores.
Geographic Coverage
The countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives the growth in the North America
region as it is the largest market in the region. The Asia-pacific region offers a
substantial potential for the market growth owing to rapid growth in markets such
as India and China. The APAC region is projected to experience a growth at a CAGR
of x.x% over the period of 2018-2024.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global muscle relaxants drugs
market such as, Abbott Laboratories, Mallinckrodt plc. Medtronic Neuromodulation
(Medtronic Inc.), Vertical Pharmaceuticals LLC, Johnson & Johnson, Par Sterile
Products, LLC. Endo Pharmaceuticals, Inc., SteriMax Inc., Upsher Smith
Laboratories, Inc. and Orient Pharma Co., Ltd.
3
© Infinium Global Research